Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection

PloS One
Inga OhsWibke Bayer

Abstract

Interleukins (IL) are cytokines with stimulatory and modulatory functions in the immune system. In this study, we have chosen interleukins which are involved in the enhancement of TH2 responses and B cell functions to analyze their potential to improve a prophylactic adenovirus-based anti-retroviral vaccine with regard to antibody and virus-specific CD4(+) T cell responses. Mice were vaccinated with an adenoviral vector which encodes and displays the Friend Virus (FV) surface envelope protein gp70 (Ad.pIXgp70) in combination with adenoviral vectors encoding the interleukins IL4, IL5, IL6, IL7 or IL23. Co-application of Ad.pIXgp70 with Ad.IL5, Ad.IL6 or Ad.IL23 resulted in improved protection with high control over FV-induced splenomegaly and reduced viral loads. Mice co-immunized with adenoviral vectors encoding IL5 or IL23 showed increased neutralizing antibody responses while mice co-immunized with Ad.IL6 or Ad.IL23 showed improved FV-specific CD4(+) T cell responses compared to mice immunized with Ad.pIXgp70 alone. We show that the co-application of adenoviral vectors encoding specific interleukins is suitable to improve the vaccination efficacy of an anti-retroviral vaccine. Improved protection correlated with improved CD4(...Continue Reading

References

Jan 1, 1989·International Immunology·R MurrayA Zlotnik
Jul 1, 1995·AIDS Research and Human Retroviruses·M GardnerE Robinson
Apr 1, 1995·The Journal of Experimental Medicine·U von Freeden-JeffryR Murray
Feb 1, 1994·Journal of Medical Primatology·M B GardnerM MacKenzie
Jul 1, 1993·The Journal of Experimental Medicine·K H GrabsteinP J Morrissey
Nov 1, 1996·Journal of Virology·N MitterederB C Trapnell
May 9, 2001·Blood·T J FryC L Mackall
May 18, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·Y ZhangJ M Wilson
Dec 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sang-Jun HaYoung-Chul Sung
Aug 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ronald J MesserKim J Hasenkrug
Nov 17, 2006·The Journal of Infectious Diseases·Punnee PitisuttithumUNKNOWN Bangkok Vaccine Evaluation Group
Sep 5, 2007·Cytokine·Christina Kittipatarin, Annette R Khaled
May 16, 2008·Immunology·Jane Gilmour, Paul Lavender
Jan 24, 2009·Immunological Reviews·Katia BonifaceRené de Waal Malefyt
Oct 13, 2009·International Immunology·Taku Kouro, Kiyoshi Takatsu
Oct 22, 2009·The New England Journal of Medicine·Supachai Rerks-NgarmUNKNOWN MOPH-TAVEG Investigators
Apr 23, 2010·International Immunology·Tadamitsu Kishimoto
Nov 26, 2010·Human Genomics·Chad BrockerVasilis Vasiliou
Mar 17, 2012·Seminars in Immunology·Steven A Corfe, Christopher J Paige
Jul 20, 2012·Journal of Virology·Matthias TenbuschKlaus Uberla

❮ Previous
Next ❯

Citations

May 27, 2014·AIDS Research and Human Retroviruses·Madeline OdigieShyam Kottilil
Jan 1, 2014·Vaccines·Rachel StephensonIstvan Toth
Sep 10, 2014·Frontiers in Microbiology·Beatrice O Ondondo
Jan 1, 2020·Expert Review of Vaccines·Lasse NeukirchPeter Johannes Holst

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISAs
transfection
ELISA

Software Mentioned

FlowJo
GraphPad Prism

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.